These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 26239914)

  • 21. Advances in stem-cell--generated transplantation therapy for Parkinson's disease.
    Sundberg M; Isacson O
    Expert Opin Biol Ther; 2014 Apr; 14(4):437-53. PubMed ID: 24437368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization and criteria of embryonic stem and induced pluripotent stem cells for a dopamine replacement therapy.
    Cooper O; Parmar M; Isacson O
    Prog Brain Res; 2012; 200():265-76. PubMed ID: 23195423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of Parkinson's disease using cell transplantation.
    Lindvall O
    Philos Trans R Soc Lond B Biol Sci; 2015 Oct; 370(1680):20140370. PubMed ID: 26416681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pluripotent stem cells as new drugs? The example of Parkinson's disease.
    Preynat-Seauve O; Burkhard PR; Villard J; Zingg W; Ginovart N; Feki A; Dubois-Dauphin M; Hurst SA; Mauron A; Jaconi M; Krause KH
    Int J Pharm; 2009 Nov; 381(2):113-21. PubMed ID: 19782880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging restorative treatments for Parkinson's disease: manipulation and inducement of dopaminergic neurons from adult stem cells.
    Zhao J; Xu Q
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):509-16. PubMed ID: 21495964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stem Cell Therapy for Parkinson's Disease.
    Han F; Hu B
    Adv Exp Med Biol; 2020; 1266():21-38. PubMed ID: 33105493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell replacement therapy for Parkinson's disease: how close are we to the clinic?
    Ganz J; Lev N; Melamed E; Offen D
    Expert Rev Neurother; 2011 Sep; 11(9):1325-39. PubMed ID: 21864078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stem cell-based therapy for Parkinson's disease.
    Correia AS; Anisimov SV; Li JY; Brundin P
    Ann Med; 2005; 37(7):487-98. PubMed ID: 16278162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical application of stem cell therapy in Parkinson's disease.
    Politis M; Lindvall O
    BMC Med; 2012 Jan; 10():1. PubMed ID: 22216957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease.
    Hallett PJ; Deleidi M; Astradsson A; Smith GA; Cooper O; Osborn TM; Sundberg M; Moore MA; Perez-Torres E; Brownell AL; Schumacher JM; Spealman RD; Isacson O
    Cell Stem Cell; 2015 Mar; 16(3):269-74. PubMed ID: 25732245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neural stem cells and transplantation studies in Parkinson's disease.
    Pardal R; López-Barneo J
    Adv Exp Med Biol; 2012; 741():206-16. PubMed ID: 22457112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional Rescue of Dopaminergic Neuron Loss in Parkinson's Disease Mice After Transplantation of Hematopoietic Stem and Progenitor Cells.
    Altarche-Xifro W; di Vicino U; Muñoz-Martin MI; Bortolozzi A; Bové J; Vila M; Cosma MP
    EBioMedicine; 2016 Jun; 8():83-95. PubMed ID: 27428421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopaminergic precursors differentiated from human blood-derived induced neural stem cells improve symptoms of a mouse Parkinson's disease model.
    Yuan Y; Tang X; Bai YF; Wang S; An J; Wu Y; Xu ZD; Zhang YA; Chen Z
    Theranostics; 2018; 8(17):4679-4694. PubMed ID: 30279731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of stem cells in regenerative medicine for Parkinson's and Huntington's Diseases.
    Lescaudron L; Naveilhan P; Neveu I
    Curr Med Chem; 2012; 19(35):6018-35. PubMed ID: 22963567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and Differentiation of Midbrain Dopaminergic Neuron: From Bench to Bedside.
    Wang M; Ling KH; Tan JJ; Lu CB
    Cells; 2020 Jun; 9(6):. PubMed ID: 32570916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic potentials of human embryonic stem cells in Parkinson's disease.
    Newman MB; Bakay RA
    Neurotherapeutics; 2008 Apr; 5(2):237-51. PubMed ID: 18394566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human amniotic epithelial stem cell-derived dopaminergic neuron-like cells ameliorate motor dysfunction in a rat model of Parkinson's disease.
    Jiang T; Huang J; Xu B; Ge Z; Li Y; Wei L; Yu L; Li J
    Life Sci; 2024 Aug; 351():122816. PubMed ID: 38862064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rewiring the brain with cell transplantation in Parkinson's disease.
    Gaillard A; Jaber M
    Trends Neurosci; 2011 Mar; 34(3):124-33. PubMed ID: 21316770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell transplantation in the damaged adult brain.
    Jaber M; Benoit-Marand M; Prestoz L; Gaillard A
    Rev Neurol (Paris); 2013 Nov; 169(11):838-43. PubMed ID: 24112517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immature Midbrain Dopaminergic Neurons Derived from Floor-Plate Method Improve Cell Transplantation Therapy Efficacy for Parkinson's Disease.
    Qiu L; Liao MC; Chen AK; Wei S; Xie S; Reuveny S; Zhou ZD; Hunziker W; Tan EK; Oh SKW; Zeng L
    Stem Cells Transl Med; 2017 Sep; 6(9):1803-1814. PubMed ID: 28650520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.